Cargando…
Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification
Rapid detection of severe fever with thrombocytopenia syndrome virus (SFTSV) is crucial for its control and surveillance. In this study, a rapid isothermal real-time reverse-transcription recombinase polymerase amplification (RT-RPA) assay was developed for the detection of SFTSV. The detection limi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172814/ https://www.ncbi.nlm.nih.gov/pubmed/32330556 http://dx.doi.org/10.1016/j.mcp.2020.101580 |
_version_ | 1783524330688217088 |
---|---|
author | Zhou, Jingyu Wang, Qiujing Zhu, Lijun Li, Shibo Li, Wei Fu, Yongfeng Cheng, Xunjia |
author_facet | Zhou, Jingyu Wang, Qiujing Zhu, Lijun Li, Shibo Li, Wei Fu, Yongfeng Cheng, Xunjia |
author_sort | Zhou, Jingyu |
collection | PubMed |
description | Rapid detection of severe fever with thrombocytopenia syndrome virus (SFTSV) is crucial for its control and surveillance. In this study, a rapid isothermal real-time reverse-transcription recombinase polymerase amplification (RT-RPA) assay was developed for the detection of SFTSV. The detection limit at 95% probability was 241 copies per reaction. A test of 120 serum samples of suspected severe fever with thrombocytopenia syndrome (SFTS) patients revealed that the sensitivity and specificity of the RT-RPA assay was approximately 96.00% (95%CI: 80.46%–99.79%) and 98.95% (95% CI: 94.28%–99.95%), respectively; the kappa value was 0.9495 (P<0.001). The Bland-Altman analysis showed that 87.50% of the different data points were located within the 95% limits of agreement, indicating a good correlation between the results from RT-RPA assays and those of RT-qPCR assays. In conclusion, the rapid and efficient RT-RPA assay can be a promising candidate for point-of-care detection method of SFTSV. |
format | Online Article Text |
id | pubmed-7172814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71728142020-04-22 Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification Zhou, Jingyu Wang, Qiujing Zhu, Lijun Li, Shibo Li, Wei Fu, Yongfeng Cheng, Xunjia Mol Cell Probes Article Rapid detection of severe fever with thrombocytopenia syndrome virus (SFTSV) is crucial for its control and surveillance. In this study, a rapid isothermal real-time reverse-transcription recombinase polymerase amplification (RT-RPA) assay was developed for the detection of SFTSV. The detection limit at 95% probability was 241 copies per reaction. A test of 120 serum samples of suspected severe fever with thrombocytopenia syndrome (SFTS) patients revealed that the sensitivity and specificity of the RT-RPA assay was approximately 96.00% (95%CI: 80.46%–99.79%) and 98.95% (95% CI: 94.28%–99.95%), respectively; the kappa value was 0.9495 (P<0.001). The Bland-Altman analysis showed that 87.50% of the different data points were located within the 95% limits of agreement, indicating a good correlation between the results from RT-RPA assays and those of RT-qPCR assays. In conclusion, the rapid and efficient RT-RPA assay can be a promising candidate for point-of-care detection method of SFTSV. Elsevier Ltd. 2020-08 2020-04-21 /pmc/articles/PMC7172814/ /pubmed/32330556 http://dx.doi.org/10.1016/j.mcp.2020.101580 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhou, Jingyu Wang, Qiujing Zhu, Lijun Li, Shibo Li, Wei Fu, Yongfeng Cheng, Xunjia Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title_full | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title_fullStr | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title_full_unstemmed | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title_short | Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
title_sort | development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172814/ https://www.ncbi.nlm.nih.gov/pubmed/32330556 http://dx.doi.org/10.1016/j.mcp.2020.101580 |
work_keys_str_mv | AT zhoujingyu developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT wangqiujing developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT zhulijun developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT lishibo developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT liwei developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT fuyongfeng developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification AT chengxunjia developmentandevaluationofarapiddetectionassayforseverefeverwiththrombocytopeniasyndromevirusbasedonreversetranscriptionrecombinasepolymeraseamplification |